ImmunityBio Financials - Benzinga

ImmunityBio Inc

IBRXNASDAQ

Trade with Public

Trade with Public

$8.48

0.020.24%

At close: Sep 18, 5:00 PM EST

$8.50

0.020.24%

After Hours: Sep 18, 7:52 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

ImmunityBio Financials

ImmunityBio (IBRX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
ImmunityBio Q2 Adj. EPS $(0.08) Beats $(0.09) Estimate, Sales $51.240M Beat $49.700M Estimate

ImmunityBio (NASDAQ:IBRX) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.09) by 11.11 percent. This is a 20 percent increase over losses of $(0.10) per share from the

Benzinga Newsdesk

ImmunityBio Stock Drops After Earnings Miss Despite Anktiva Momentum

ImmunityBio shares fall after Q1 losses misses estimates despite strong ANKTIVA sales growth and updated bladder cancer treatment guidelines.

Vandana Singh

PRO
UPDATE: ImmunityBio Q1 Adj. EPS $(0.08) Misses $(0.07) Estimate, Sales $44.206M Beat $43.069M Estimate

ImmunityBio (NASDAQ:IBRX) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.07) by 14.29 percent. This is a 20 percent increase over losses of $(0.10) per share from the

Benzinga Newsdesk

PRO
ImmunityBio Q1 EPS $(0.62) Misses $(0.07) Estimate, Sales $44.206M Beat $43.069M Estimate

ImmunityBio (NASDAQ:IBRX) reported quarterly losses of $(0.62) per share which missed the analyst consensus estimate of $(0.07) by 785.71 percent. This is a 313.33 percent decrease over losses of $(0.15) per share from

Benzinga Newsdesk

Why Is ImmunityBio Stock Rallying Thursday?

ImmunityBio stock rises as Q1 revenue jumps 168% and Anktiva adoption grows, even as FDA warning prompts review of promotional claims.

Vandana Singh

ImmunityBio Supersedes Expectations With Fivefold Revenue Increase

ImmunityBio stock climbs after Anktiva sales surge 750%, revenue beats estimates, and new Saudi partnership fuels growth.

Vandana Singh